NCT05041127 2026-02-19
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
13 trialsNCT04416568 2025-12-17
Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT00496119 2025-12-16
Proton Beam Therapy for Chordoma Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03083678 2025-02-13
Afatinib in Locally Advanced and Metastatic Chordoma
Leiden University Medical Center
Phase 2 Completed
NCT06794645 2025-01-27
Pembrolizumab and Pemetrexed for Progressive Chordoma
Saint John's Cancer Institute
Phase 2 Recruiting
NCT03623854 2024-04-16
Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT03242382 2024-01-23
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Unknown
NCT01811394 2023-12-06
ISAC
Heidelberg University
Phase 2 Unknown
NCT06140732 2023-11-20
Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Xuanwu Hospital, Beijing
Phase 2 Unknown
NCT03110744 2023-03-27
NCT-PMO-1601
University Hospital Heidelberg
Phase 2 Completed
NCT01966809 2019-08-20
Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Medical College of Wisconsin
Phase 2 Terminated
NCT04042597 2019-08-05
CSSG-03
Peking University People's Hospital
Phase 2 Unknown
NCT00464620 2018-11-23
Trial of Dasatinib in Advanced Sarcomas
Sarcoma Alliance for Research through Collaboration
Phase 2 Completed